Metrasens

About Metrasens

Metrasens is a provider of advanced magnetic and ferromagnetic detection technologies for security and safety applications. Founded in 2005 by Dr. Simon Goodyear, Dr. Mark Keene, and Matt Wooliscroft, the company originated as a spin-out from the international defense firm QinetiQ. The founders, all experts in magnetic detection with extensive experience, aimed to apply cutting-edge science to real-world security challenges.

The company designs and manufactures detection systems to screen for threat items in various settings, including healthcare, corrections, data security, and public venues like stadiums and schools. Its client base spans both public and private institutions, such as government facilities, hospitals, and corporate enterprises. Metrasens operates globally, with a technology and manufacturing center in the UK, a North American hub in Chicago, and a worldwide distributor network.

Metrasens' core product line utilizes ferromagnetic detection (FMDS) technology. Products include the 'Proscreen' series for weapons detection in public spaces, 'Cellsense' for finding contraband in correctional facilities, and 'Ferroguard' to prevent projectile risks in MRI facilities. A key offering is Metrasens Ultra™, a system featuring Xact ID™ intelligent detection technology, designed to identify a wide range of threats from guns to small blades and concealed electronics. The systems are engineered to be portable, flexible, and less intrusive than conventional screening methods, allowing for high throughput of people with minimal disruption.